Microbiopsy-based minimally invasive skin sampling for molecular analysis is acceptable to Epidermolysis Bullosa Simplex patients where conventional diagnostic biopsy was refused

Yamada, M.Melville, E.Cowin, A.J.Prow, T.W.Kopecki, Z.2020-12-072020-12-072021Skin Research and Technology, 2021; 27(3):461-4630909-752X1600-0846http://hdl.handle.net/2440/129314Letter to the EditorAbstract not available.en© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons LtdSkinHumansEpidermolysis Bullosa SimplexBiopsySpecimen HandlingMicrobiopsy-based minimally invasive skin sampling for molecular analysis is acceptable to Epidermolysis Bullosa Simplex patients where conventional diagnostic biopsy was refusedJournal article100002739010.1111/srt.129710005817667000012-s2.0-85093122736550959Cowin, A.J. [0000-0003-2885-2080]Kopecki, Z. [0000-0002-8072-4222]